Prescription Medications with Generic Names Beginning ‘D’

Page 1 of 423 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Pradaxa (Dabigatran Etexilate)

PRADAXA Oral Pellets are a direct thrombin inhibitor indicated: For the treatment of venous thromboembolic events (VTE) in pediatric patients aged 3 months to less than 12 years of age…

Boehringer Ingelheim Pharmaceuticals, Inc.1 April 2022

Dabigatran Etexilate

Dabigatran Etexilate Capsules is a direct thrombin inhibitor indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (1.1)…

Ascend Laboratories, LLC23 June 2022

Dabigatran Etexilate

Dabigatran etexilate capsules are a direct thrombin inhibitors indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (1.1)…

American Health Packaging30 March 2023

Dabigatran Etexilate

Dabigatran etexilate capsules are a direct thrombin inhibitors indicated: To reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (1…

Camber Pharmaceuticals, Inc.15 April 2023

PRADAXA (Dabigatran Etexilate Mesylate)

PRADAXA is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. PRADAXA is a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with…

Rebel Distributors Corp23 November 2010

Page 1 of 423 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

RxDrugLabels

Medication Sections

Medication Information by RSS

About

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.